Solesta, an injectable gel delivered into the anal canal in an outpatient procedure, is a minimally invasive treatment option.
The FDA previously noted difficulties in treating fecal incontinence.
Related Articles on Incontinence:
FDA Approves Solesta to Treat Life-Altering Fecal Incontinence
FDA Gastroenterology and Urology Device Panel Approves Fecal Incontinence Product
USC Colorectal Surgeon Andreas Kaiser Named GI Journal Editor
Next Up in GI & Endoscopy
-
Jacksonville, Fla.-based Borland Groover opened a gastroenterology office Nov. 16 in St. Johns County, the Jacksonville Daily Record reported. The…
-
Nutrition and gastroenterology seem like a natural fit, but one Illinois GI group leader said few practices have put them…
-
CMS’ final 2027 outpatient and ASC payment rule gives centers a 2.3% update, and GI leaders said many endoscopy procedures…
Stay current with ASC Review.
Becker's ASC Review Newsletter is sent Monday–Saturday.